Thermo Fisher Scientific TMO

NYSE · Measuring & Controlling Devices, Nec · $261.1B
$676.94−4.14%Nov 5 close · Databento
Every report since 2023 →
🔒 Click to interact · scroll moves the page
TMO Wire Story Reactions & EOD Technical StudyDaily closes (Databento EOD) pinned with every AlgoThesis Wire story (dot colour = next trading day close) and SEC filing
Nov 5, 2026CLOSE $676.941D −4.14%3M +12.88%SMA20 $685.32SMA50 $659.53RSI(14) 49.2
676.94
RSI (14, Wilder EOD) · 70 Overbought / 30 OversoldRSI 49.2

Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.

The numbers

fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$261.1B
EV / True FCF49.1x
Revenue$44.6B +3.9%
True FCF (ex-SBC)$6.0B −13.4%
Rule of 4018.0%
ROIC8.3%
True FCF Yield2.3%
EPS, diluted$17.74 +7.3%
Modern Valuation (EOD)
Market Cap$261.1B
Enterprise Value$293.9B
EV / True FCF49.13
EV / FCF46.71
EV / Gross Profit—
EV / EBIT37.95
EV / Sales6.60
P / E (GAAP)38.85
P / FCF41.49
P / Oper. CF33.40
P / Book4.89
Owner & Cash Yields
True FCF Yield2.3%
FCF Yield2.4%
Owner Earn. Yield2.3%
Earnings Yield2.6%
Shareholder Yield+1.3%
Buyback Yield1.1%
Dividend Yield0.25%
Dividend / sh$1.72
Payout Ratio10%
FCF / sh$16.98
EPS (diluted)$17.74
Compounder & Returns
Rule of 4018.0%
ROIC8.3%
Cash ROIC (CROIC)7.3%
GP / Assets—
ROE12.6%
ROA6.1%
Gross Margin—
Oper. Margin17.4%
Net Margin15.1%
FCF Margin14.1%
True FCF Margin13.4%
Quality & Dilution
Cash Conversion94%
Accrual Ratio−1.0%
SBC % of FCF4.9%
SBC % of Rev0.7%
Reinvest. Rate37%
Sales Growth Y/Y+3.9%
Sales 3Y CAGR−0.3%
EPS Growth Y/Y+7.3%
FCF Growth Y/Y−13.4%
FCF 3Y CAGR−3.1%
Share Change Y/Y−1.3%
Balance Sheet & Scale
Revenue (FY)$44.6B
Gross Profit (FY)—
Oper. Income (FY)$7.7B
GAAP Net Income$6.7B
True FCF (ex-SBC)$6.0B
Cash & Equiv$9.9B
Total Debt$42.7B
Net Cash (Debt)$-32.8B
Net Cash % MCap−12.6%
Debt / FCF (yrs)6.8y
Current Ratio1.89370.52M sh
Price & Technicals (EOD)
Perf Week−4.55%
Perf Month+2.25%
Perf Quarter+13.96%
Perf Half Y+42.68%
Perf YTD+28.69%
SMA 20 Dist−1.22%$685.32
SMA 50 Dist+2.64%$659.53
SMA 100 Dist+11.83%$605.32
Window High−4.55%$709.18
Window Low+54.43%$438.34
RSI (14) · Vol49.229%v
Income Distribution & Cash Flow ConversionHow every dollar of TMO revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
REVENUE · 100%$44.6BGROSS PROFIT · 79.9%$35.6BCOST OF REV · 20.1%$9.0BOPER. INCOME · 17.4%$7.7BOPEX · 62.5%R&D $1.4B · SG&A $8.7BNET INCOME · 15.1%$6.7B
Where Every $100 of Revenue Goes (FY2025)
Cost of Revenue (COGS)$9.0B ($20.1 / $100)
R&D Reinvestment$1.4B ($3.1 / $100)
SG&A & Other OpEx$26.4B ($59.3 / $100)
Tax & Non-Operating$1.0B ($2.3 / $100)
Net Profit Kept$6.7B ($15.1 / $100)
Earnings Quality: GAAP Profit → True Owner Cash (FY2025)
GAAP Net Income$6.7B (15.1% margin)
Operating Cash Flow (OCF)$7.8B(17.5% of rev)
Less: Capital Expenditures−$1.5B(3.4% of rev)
Standard Free Cash Flow (FCF)$6.3B(14.1% margin)
Less: Stock-Based Comp (SBC)−$310.0M(4.9% of FCF)
True FCF (Owner Cash ex-SBC)$6.0B(13.4% of rev)

Operating leverage — margins

GrossOperatingNet
0%40%80%17%15%FY21FY22FY23FY24FY25
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)FY2021FY2022FY2023FY2024FY2025YoY Δ4Y CAGRTrend
Income Statement
Cost of Revenue (COGS)————$9.0B——
Research & Development (R&D)$1.4B$1.5B$1.3B$1.4B$1.4B+0.5%−0.2%
Selling, General & Admin (SG&A)$8.0B$9.0B$8.4B$8.6B$8.7B+1.6%+2.2%
Interest Expense$536.0M$726.0M$1.4B$1.4B$1.4B+2.1%+27.6%
Income Tax Expense$1.1B$703.0M$284.0M$657.0M$547.0M−16.7%−16.2%
Diluted Shares397.0M394.0M388.0M383.0M378.0M−1.3%−1.2%
Balance Sheet
Cash & Equivalents$4.5B$8.5B$8.1B$4.0B$9.9B+144.5%+21.8%
Inventory$5.1B$5.6B$5.1B$5.0B$5.4B+9.0%+1.8%
Total Current Assets$20.1B$25.2B$24.6B$22.1B$28.7B+29.7%+9.3%
Total Assets$95.1B$97.2B$98.7B$97.3B$110.3B+13.4%+3.8%
Total Current Liabilities$13.4B$17.0B$14.0B$13.3B$15.2B+13.9%+3.1%
Total Debt (Short + Long Term)$37.2B$39.9B$38.3B$33.3B$42.7B+28.3%+3.5%
Stockholders' Equity$40.9B$44.0B$46.7B$49.6B$53.4B+7.8%+6.9%
Net Cash / (Net Debt)$-32.7B$-31.3B$-30.2B$-29.2B$-32.8B−12.2%—
Invested Capital$73.6B$75.4B$77.0B$78.8B$86.2B+9.4%+4.1%
Cash Flow & Capital Allocation
Depreciation & Amortization (D&A)$831.0M$986.0M$1.1B$1.2B$1.1B−9.2%+6.0%
Stock-Based Compensation (SBC)$230.0M$307.0M$278.0M$301.0M$310.0M+3.0%+7.7%
Capital Expenditures (CapEx)$2.5B$2.2B$1.5B$1.4B$1.5B+8.9%−11.8%
True FCF (ex-SBC Owner Cash)$6.6B$6.6B$6.6B$7.0B$6.0B−14.1%−2.3%
Share Repurchases (Buybacks)$2.0B$3.0B$3.0B$4.0B$3.0B−25.0%+10.7%
Dividends Paid$395.0M$455.0M$523.0M$583.0M$636.0M+9.1%+12.6%

Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.

On the Wire

what TMO did at the next close after each story

No Wire story has named TMO yet.

The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.